PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31653830 ↗2019Mixed findings

Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction.

MouseIschaemia-reperfusionCardiacC57BL/6 (Cx3cr1-EGFP mice used for monocyte tracking)Femalen = Three to fifteen mice per group as specified in figure lege…Intramyocardial injection via 27-G needle, ultrasound-guided closed-chest procedureFive equivolumetric intramyocardial injections of 10 uL eac…1 week after myocardial infarction, at the end of the proliferative phase

Model: Permanent ligation of the left anterior descending coronary artery via fourth intercostal thoracotomy

rHCI improved ejection fraction from 34.6 plus or minus 1.6% to 44.2 plus or minus 1.9% at 28 days, reduced scar size by about 37%, maintained remote wall thickness and increased border zone capillaries and pro-healing macrophages, whereas rHCIII preserved but did not improve function and PBS-treat…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.